Rocket Lab's Record Revenue and $90M Defense Win Overshadowed by Insider Sales and Neutron Delays
04.06.2026 - 16:02:01 | boerse-global.de
Rocket Lab's stock slid roughly seven percent on Wednesday, closing at $114.70 as the market reassessed how much of the company's ambitious future is already baked into the price. The pullback—which clipped a rally that had briefly lifted shares to $151—was accompanied by heavy trading volume of 20.9 million shares, near the daily average. Despite the dip, the stock remains well above its 50-day moving average of $93.14 and its 200-day line of $76.94, underscoring how dramatically the valuation has been re-rated in recent months.
That re-rating rests on a solid operational foundation. In the first quarter, Rocket Lab posted record revenue of $200.3 million, a 63.5% year-over-year surge. GAAP gross margin came in at 38.2%, while the net loss narrowed to $45 million from $60.6 million a year earlier. The company ended March with roughly $1.38 billion in cash and short-term securities—a comfortable cushion that also includes additional liquidity beyond pure cash. For the current quarter, management expects revenue between $225 million and $240 million, with adjusted EBITDA losses of $20 million to $26 million.
The real story, however, is the accelerating transformation from launch provider to vertically integrated space systems and defense contractor. The contract backlog hit a record $2.22 billion, up 20% from the prior quarter and more than double the year-ago level. A book-to-bill ratio of 2.86x means new orders are far outstripping deliveries, with over 70 launches already on the manifest. The most recent win came on May 21, when the U.S. Space Force awarded Rocket Lab a $90 million contract to design, build, and operate two geostationary satellites carrying the Heimdall space surveillance system. It marks the company's first satellite program for geostationary orbit and positions Rocket Lab as a systems integrator for military and space infrastructure—not just a rocket company.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
That strategic shift has caught the eye of defense agencies. Rocket Lab recently completed the System Requirements Review for the Space Development Agency's Tranche 3 Tracking Layer constellation, a program aimed at equipping satellites with advanced missile-defense and tracking capabilities tied to the U.S. "Golden Dome" initiative. Yet for all the progress, the market is wrestling with two counterweights: insider selling and the delayed Neutron rocket.
SEC filings reveal notable insider activity. In the past three months, executives and directors have sold a total of 524,120 shares, worth roughly $67.7 million. CFO Adam Spice was among those who sold, though he also made gift transfers of 188,172 shares at zero dollar value. He still holds 920,325 shares directly and another 250,000 indirectly through a trust. President Marvin Bradford Clevenger sold 3,500 shares at an average price of $146.67 on May 28, retaining 473,975 shares. While the selling is substantial, insiders collectively still own 8.4% of the company—a level that suggests confidence remains, even if some are locking in gains.
The bigger wild card is Neutron. After a structural failure during a hydrostatic pressure test in January 2026, the first flight of the medium-lift rocket was pushed to late 2026. Five dedicated launch contracts are already secured, and the project remains central to Rocket Lab's path toward profitability. The company targets its first positive adjusted EBITDA in fiscal 2027, with a goal of $100 million at a 7.6% margin, driven by Neutron's commercialization and scaled satellite production. Until then, Rocket Lab remains a growth story dependent on trust in its roadmap—and on a smooth first flight for Neutron before the year is out.
Wednesday's sell-off was not an isolated event. Earlier volatility was triggered by a rocket accident at a competitor, which briefly knocked the stock down 14.8%. The price recovered to around $114.78 by June 2, but the backdrop remains choppy, with the looming SpaceX IPO on June 12 adding another layer of uncertainty. For now, the market is waiting to see whether Rocket Lab can hit its second-quarter revenue guidance and narrow losses as planned. The next earnings report will test whether the current valuation has substance—or whether Wednesday's retreat is merely the opening act.
Ad
Rocket Lab USA Stock: New Analysis - 4 June
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
